This one has a reasonably settled answer, so here it is. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.
I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
What I am trying to establish is how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
I would rather have one careful answer than five confident ones.
COA_Karl said:There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.
No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDerekSJ_a1c said:I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
Mine went the same way, slower. The detail I would add is minor and it is already implied above.
Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.